AGTR1 and idiopathic pulmonary fibrosis: Specifically, the increased expression of AT1 and Mas receptors in patients with IPF indicates an upregulation of tissue-specific signaling pathways, which may suggest a localized compensatory mechanism, independent of systemic peptide concentrations.